UNSPSC 51144302: Phendimetrazine bitartrate

This classification denotes a cns stimulant and anorexiant with the molecular formula C12H17NO.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6985IP0T80, chemically known as (2s,3s)-3,4-dimethyl-2-phenylmorpholine l-(+)-tartrate, but more generally known as phendimetrazine bitartrate, which bears US NIH Compound Identifier 120608. European Medicines Agency schedules phendimetrazine bitartrate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09756MIG.

Most nations, for tariff purposes, schedule phendimetrazine bitartrate under HS 29349100. SMILES: C[C@H]1[C@@H](OCCN1C)C2CCCCC2.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

UNSPSC 51144302 Phendimetrazine bitartrate is a Commodity code that in practice captures state and local procurement of pharmaceutical products and related health-system supplies, though the recent opportunities reveal significant scope drift: the tagged opportunities reflect demand for naloxone and drug deactivation systems, direct-to-manufacturer pharmacy benefit programs, and generic multi-source pharmaceuticals and over-the-counter products rather than the specific controlled-substance pharmaceutical named in the code. State and local issuing bodies using this code include county health departments, state health and human services commissions, and multistate cooperative purchasing alliances that aggregate demand across participating jurisdictions. The work being solicited spans procurement of emergency opioid-reversal medications (naloxone), safe drug disposal systems, bulk generic and OTC pharmaceutical inventory, and exploration of alternative pharmacy benefit contracting models that bypass traditional pharmacy benefit manager and group purchasing organization channels.

Seminole County, Florida issued an IFB (IFB60459723LAS, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to its community health building. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802, due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products distributed to participating state and local facilities in Minnesota and Oregon, requiring vendors to work through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson as authorized wholesalers. The Texas Health and Human Services Commission posted a Request for Information (HHS0017013, due April 3, 2026) seeking vendor input on direct-to-manufacturer prescription programs to improve cost management and fulfillment efficiency outside traditional PBM channels. Geographic activity spans Florida, Minnesota, Oregon, and Texas, with the multistate cooperative purchasing mechanism serving as a significant consolidation point for state and local pharmaceutical procurement.